Risk Factors for Patient-Important Upper Gastrointestinal Bleeding

<b>Rationale:</b> Patient-important gastrointestinal bleeding is an endpoint developed by patients and family members; however, risk factors for this outcome are unknown. <b>Objectives:</b> We sought to identify risk factors for patient-important upper gastrointestinal bleeding among invasively ventilated adults. <b>Methods:</b> This preplanned regression analysis of an international trial database evaluated baseline and time-varying risk factors in the preceding 3 days for patient-important upper gastrointestinal bleeding, accounting for illness severity and the competing risk of death. <b>Measurements and Main Results:</b> Patient-important upper gastrointestinal bleeding occurred in the ICU among 131 of 4,821 (2.7%) patients. Baseline APACHE II score-hazard ratio (HR), 1.24 (95% confidence interval [CI] = 1.12, 1.37) per 5-point increase-and the following were associated with greater risk of patient-important bleeding: inotropes or vasopressors (HR, 2.05 [95% CI = 1.35, 3.12]), severe thrombocytopenia (platelet count, <50 × 10<sup>9</sup>/L) (HR, 2.21 [95% CI = 1.24, 3.94]) and platelet inhibitor drugs (HR, 1.69 [95% CI = 1.11, 2.56]). A lower bleeding risk was associated with pantoprazole (HR, 0.36 [95% CI = 0.25, 0.54]) and enteral nutrition (HR, 0.81 [95% CI = 0.68, 0.97]) for every increase of 500 ml/d. There was no interaction between enteral nutrition and pantoprazole (interaction <i>P</i> = 0.94). Allocation to pantoprazole was associated with a lower risk of patient-important upper gastrointestinal bleeding regardless of the volume of enteral nutrition (for 500 ml/d: HR, 0.36 [95% CI = 0.22, 0.58]; for no enteral nutrition: HR, 0.36 [95% CI = 0.18, 0.72]). The association of enteral nutrition and bleeding was similar with pantoprazole (HR, 0.82 [95% CI = 0.63, 1.07]) or without pantoprazole (HR, 0.81 [95% CI = 0.66, 1.00]). <b>Conclusions:</b> Several factors are associated with the risk of patient-important upper gastrointestinal bleeding during invasive ventilation.

Authors

Institutions

Publication Details

Journal
American Journal of Respiratory and Critical Care Medicine
Published
2025-04-18
DOI
https://doi.org/10.1164/rccm.202411-2245oc
Citations
5
Primary Topic
Gastrointestinal Bleeding Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
9.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk Factors for Patient-Important Upper Gastrointestinal Bleeding

Diane Heels‐Ansdell, Nicole Zytaruk, Simon R. Finfer, François Lauzier et al.
5 citations
American Journal of Respiratory and Critical Care Medicine
Gastrointestinal Bleeding Diagnosis and Treatment
9.06
article

Risk Factors for Patient-Important Upper Gastrointestinal Bleeding

Diane Heels‐Ansdell, Nicole Zytaruk, Simon R. Finfer, François Lauzier, Karen E. A. Burns, Yaseen M. Arabi, David R. Williamson, M.J. Hardie, Lehana Thabane, Gordon Guyatt, Jeffrey F. Barletta, Salmaan Kanji, Paul Jeffrey Young, Neill K. J. Adhikari, Marlies Ostermann, Adam M. Deane, Naomi E. Hammond, Kyle White, Joanna Colleen Dionne, John C. Marshall, François Lamontagne
article en
5 citations

Abstract

<b>Rationale:</b> Patient-important gastrointestinal bleeding is an endpoint developed by patients and family members; however, risk factors for this outcome are unknown. <b>Objectives:</b> We sought to identify risk factors for patient-important upper gastrointestinal bleeding among invasively ventilated adults. <b>Methods:</b> This preplanned regression analysis of an international trial database evaluated baseline and time-varying risk factors in the preceding 3 days for patient-important upper gastrointestinal bleeding, accounting for illness severity and the competing risk of death. <b>Measurements and Main Results:</b> Patient-important upper gastrointestinal bleeding occurred in the ICU among 131 of 4,821 (2.7%) patients. Baseline APACHE II score-hazard ratio (HR), 1.24 (95% confidence interval [CI] = 1.12, 1.37) per 5-point increase-and the following were associated with greater risk of patient-important bleeding: inotropes or vasopressors (HR, 2.05 [95% CI = 1.35, 3.12]), severe thrombocytopenia (platelet count, <50 × 10<sup>9</sup>/L) (HR, 2.21 [95% CI = 1.24, 3.94]) and platelet inhibitor drugs (HR, 1.69 [95% CI = 1.11, 2.56]). A lower bleeding risk was associated with pantoprazole (HR, 0.36 [95% CI = 0.25, 0.54]) and enteral nutrition (HR, 0.81 [95% CI = 0.68, 0.97]) for every increase of 500 ml/d. There was no interaction between enteral nutrition and pantoprazole (interaction <i>P</i> = 0.94). Allocation to pantoprazole was associated with a lower risk of patient-important upper gastrointestinal bleeding regardless of the volume of enteral nutrition (for 500 ml/d: HR, 0.36 [95% CI = 0.22, 0.58]; for no enteral nutrition: HR, 0.36 [95% CI = 0.18, 0.72]). The association of enteral nutrition and bleeding was similar with pantoprazole (HR, 0.82 [95% CI = 0.63, 1.07]) or without pantoprazole (HR, 0.81 [95% CI = 0.66, 1.00]). <b>Conclusions:</b> Several factors are associated with the risk of patient-important upper gastrointestinal bleeding during invasive ventilation.

American Journal of Respiratory and Critical Care MedicineVol. 211(9)
Midwestern University (US), The University of Sydney (AU), St. Michael's Hospital (CA), The Royal Melbourne Hospital (AU), St Thomas' Hospital (GB), Université de Sherbrooke (CA), The University of Melbourne (AU), King's College London (GB), King Saud bin Abdulaziz University for Health Sciences (SA), University of Toronto (CA), Royal North Shore Hospital (AU), Ottawa Hospital (CA), Wellington Hospital (NZ), Princess Alexandra Hospital (AU), UNSW Sydney (AU), The George Institute for Global Health (AU), St. Thomas Hospital (CA), Medical Research Institute of New Zealand (NZ), Hôpital du Sacré-Cœur de Montréal (CA), Impact (CA), Université Laval (CA), Ottawa Hospital Research Institute (CA), Unity Health Toronto, Imperial College London (GB), St. Joseph’s Healthcare Hamilton (CA), Université de Montréal (CA), McMaster University (CA)
Zero hunger
Openalex Percentile: Top 2%
Gastrointestinal Bleeding Diagnosis and Treatment
9.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.